Atlas Trials

Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

Clinical trial NCT04069312 · COMPLETED

Trial details

NCT number
NCT04069312
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease SevereChronic Bronchitis
Start date
2020-02-11
Primary completion
2026-03-01
Enrollment
1032

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.